The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States
Open accessAbstract
Background: Population screening for FMR1 mutations has been a topic of considerable discussion since the FMR1 gene was identified in 1991. Advances in understanding the molecular basis of fragile X syndrome (FXS) and in genetic testing methods have led to new, less expensive methodology to use for large screening endeavors. A core criterion for newborn screening is an accurate understanding of the public health burden of a disease, considering both disease severity and prevalence rate. This article addresses this need by reporting prevalence rates observed in a pilot newborn screening study for FXS in the US. Methods: Blood spot screening of 14,207 newborns (7,312 males and 6,895 females) was conducted in three birthing hospitals across the United States beginning in November 2008, using a PCR-based approach. Results: The prevalence of gray zone alleles was 1:66 females and 1:112 males, while the prevalence of a premutation was 1:209 females and 1:430 males. Differences in prevalence rates were observed among the various ethnic groups; specifically higher frequency for gray zone alleles in males was observed in the White group compared to the Hispanic and African-American groups. One full mutation male was identified (>200 CGG repeats). Conclusions: The presented pilot study shows that newborn screening in fragile X is technically feasible and provides overall prevalence of the premutation and gray zone alleles in the USA, suggesting that the prevalence of the premutation, particularly in males, is higher than has been previously reported.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A SIMPLE PHENYLALANINE METHOD FOR DETECTING PHENYLKETONURIA IN LARGE POPULATIONS OF NEWBORN INFANTS
Guthrie, R., & Susi, A. (1963) · Pediatrics · doi:10.1542/peds.32.3.338 · Cited by 2,219
Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X
Hagerman, R. J., Leehey, M., Heinrichs, W., Tassone, F., Wilson, R., Hills, J., Grigsby, J., Gage, B., & Hagerman, P. J. (2001) · Neurology · doi:10.1212/wnl.57.1.127 · Cited by 964
Self-citationFragile X Premutation Tremor/Ataxia Syndrome: Molecular, Clinical, and Neuroimaging Correlates
Jacquemont, S., Hagerman, R. J., Leehey, M., Grigsby, J., Zhang, L., Brunberg, J. A., Greco, C., Des Portes, V., Jardini, T., Levine, R., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/374321 · Cited by 762
Self-citationPenetrance of the Fragile X–Associated Tremor/Ataxia Syndrome in a Premutation Carrier Population
Jacquemont, S. (2004) · JAMA · doi:10.1001/jama.291.4.460 · Cited by 695
(2001) · Molecular Therapy · doi:10.1006/mthe.2001.0396 · Cited by 680
Jacquemont, S., Curie, A., des Portes, V., Torrioli, M. G., Berry-Kravis, E., Hagerman, R. J., Ramos, F. J., Cornish, K., He, Y., Paulding, C., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001708 · Cited by 609
Self-citationAllingham-Hawkins, D. J., Babul-Hirji, R., Chitayat, D., Holden, J. J. A., Yang, K. T., Lee, C., Hudson, R., Gorwill, H., Nolin, S. L., Glicksman, A., et al. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990402)83:4<322::aid-ajmg17>3.0.co;2-b · Cited by 502
Association of FMR1 repeat size with ovarian dysfunction
Sullivan, A. K., Marcus, M., Epstein, M. P., Allen, E. G., Anido, A. E., Paquin, J. J., Yadav-Shah, M., & Sherman, S. L. (2005) · Human Reproduction · doi:10.1093/humrep/deh635 · Cited by 498
Watson, M. S., Mann, M. Y., Lloyd-Puryear, M. A., Rinaldo, P., & Howell, R. R. (2006) · Genetics in Medicine · doi:10.1097/01.gim.0000223891.82390.ad · Cited by 490
Co‐occurring conditions associated with FMR1 gene variations: Findings from a national parent survey
Bailey, D. B., Raspa, M., Olmsted, M., & Holiday, D. B. (2008) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32439 · Cited by 446
Self-citationIncidence of Fragile X Syndrome by Newborn Screening for Methylated FMR1 DNA
Coffee, B., Keith, K., Albizua, I., Malone, T., Mowrey, J., Sherman, S. L., & Warren, S. T. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.09.007 · Cited by 436
A pilot open label, single dose trial of fenobam in adults with fragile X syndrome
Berry-Kravis, E., Hessl, D., Coffey, S., Hervey, C., Schneider, A., Yuhas, J., Hutchison, J., Snape, M., Tranfaglia, M., Nguyen, D. V., et al. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2008.063701 · Cited by 411
Self-citationAutism Spectrum Phenotype in Males and Females with Fragile X Full Mutation and Premutation
Clifford, S., Dissanayake, C., Bui, Q. M., Huggins, R., Taylor, A. K., & Loesch, D. Z. (2007) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-006-0205-z · Cited by 377
Rousseau, F., Rouillard, P., Morel, M. L., Khandjian, E. W., & Morgan, K. (1995) · Europe PMC (PubMed Central) · Cited by 361
Expanded clinical phenotype of women with the FMR1 premutation
Coffey, S. M., Cook, K., Tartaglia, N., Tassone, F., Nguyen, D. V., Pan, R., Bronsky, H. E., Yuhas, J., Borodyanskaya, M., Grigsby, J., et al. (2008) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32060 · Cited by 351
Self-citationTassone, F., Pan, R., Amiri, K., Taylor, A. K., & Hagerman, P. J. (2008) · The Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2008.070073 · Cited by 350
Self-citationThe fragile X prevalence paradox
Hagerman, P. J. (2008) · Journal of Medical Genetics · doi:10.1136/jmg.2008.059055 · Cited by 342
Berry-Kravis, E. M., Hessl, D., Rathmell, B., Zarevics, P., Cherubini, M., Walton-Bowen, K., Mu, Y., Nguyen, D. V., Gonzalez-Heydrich, J., Wang, P. P., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004214 · Cited by 328
Self-citationFARZIN, F., PERRY, H., HESSL, D., LOESCH, D., COHEN, J., BACALMAN, S., GANE, L., TASSONE, F., HAGERMAN, P., & HAGERMAN, R. (2006) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/00004703-200604002-00012 · Cited by 325
Self-citationPenetrance of FMR1 premutation associated pathologies in fragile X syndrome families
Rodriguez-Revenga, L., Madrigal, I., Pagonabarraga, J., Xunclà, M., Badenas, C., Kulisevsky, J., Gomez, B., & Milà, M. (2009) · European Journal of Human Genetics · doi:10.1038/ejhg.2009.51 · Cited by 325
Fragile-X–Associated Tremor/Ataxia Syndrome (FXTAS) in Females with the FMR1 Premutation
Hagerman, R. J., Leavitt, B. R., Farzin, F., Jacquemont, S., Greco, C. M., Brunberg, J. A., Tassone, F., Hessl, D., Harris, S. W., Zhang, L., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/420700 · Cited by 325
Self-citationCordeiro, L., Ballinger, E., Hagerman, R., & Hessl, D. (2011) · Journal of Neurodevelopmental Disorders · doi:10.1007/s11689-010-9067-y · Cited by 316
Self-citationDombrowski, C. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.4.371 · Cited by 289
Fragile-X syndrome and fragile X-associated tremor/ataxia syndrome: two faces of FMR1
Jacquemont, S., Hagerman, R. J., Hagerman, P. J., & Leehey, M. A. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70676-7 · Cited by 282
Self-citationFilipovic-Sadic, S., Sah, S., Chen, L., Krosting, J., Sekinger, E., Zhang, W., Hagerman, P. J., Stenzel, T. T., Hadd, A. G., Latham, G. J., et al. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2009.136101 · Cited by 278
Self-citationMood and anxiety disorders in females with the FMR1 premutation
Roberts, J. E., Bailey, D. B., Mankowski, J., Ford, A., Sideris, J., Weisenfeld, L. A., Heath, T. M., & Golden, R. N. (2009) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30786 · Cited by 244
Self-citationMaddalena, A., Richards, C. S., McGinniss, M. J., Brothman, A., Desnick, R. J., Grier, R. E., Hirsch, B., Jacky, P., McDowell, G. A., Popovich, B., et al. (2001) · Genetics in Medicine · doi:10.1097/00125817-200105000-00010 · Cited by 231
Fragile-X Carrier Screening and the Prevalence of Premutation and Full-Mutation Carriers in Israel
Toledano-Alhadef, H., Basel-Vanagaite, L., Magal, N., Davidov, B., Ehrlich, S., Drasinover, V., Taub, E., Halpern, G. J., Ginott, N., & Shohat, M. (2001) · The American Journal of Human Genetics · doi:10.1086/321974 · Cited by 228
Open-label add-on treatment trial of minocycline in fragile X syndrome.
Paribello, C., Tao, L., Folino, A., Berry-Kravis, E., Tranfaglia, M., Ethell, I. M., & Ethell, D. W. (2010) · BMC Neurology · doi:10.1186/1471-2377-10-91 · Cited by 223
Self-citationFernandez-Carvajal, I., Walichiewicz, P., Xiaosen, X., Pan, R., Hagerman, P. J., & Tassone, F. (2009) · The Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2009.080173 · Cited by 204
Self-citationHeterozygous fragile X female: Historical, physical, cognitive, and cytogenetic features
Cronister, A., Schreiner, R., Wittenberger, M., Amiri, K., Harris, K., & Hagerman, R. J. (1991) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320380221 · Cited by 193
Self-citationLifetime Prevalence of Mood and Anxiety Disorders in Fragile X Premutation Carriers
Bourgeois, J. A., Seritan, A. L., Casillas, E. M., Hessl, D., Schneider, A., Yang, Y., Kaur, I., Cogswell, J. B., Nguyen, D. V., & Hagerman, R. J. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05407blu · Cited by 190
Self-citationPrevalence of CGG expansions of the FMR1 gene in a US population‐based sample
Seltzer, M. M., Baker, M. W., Hong, J., Maenner, M., Greenberg, J., & Mandel, D. (2012) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32065 · Cited by 189
Bretherick, K. L., Fluker, M. R., & Robinson, W. P. (2005) · Human Genetics · doi:10.1007/s00439-005-1326-8 · Cited by 182
Chen, L., Hadd, A., Sah, S., Filipovic-Sadic, S., Krosting, J., Sekinger, E., Pan, R., Hagerman, P. J., Stenzel, T. T., Tassone, F., et al. (2010) · The Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2010.090227 · Cited by 182
Self-citationBodega, B., Bione, S., Dalprà, L., Toniolo, D., Ornaghi, F., Vegetti, W., Ginelli, E., & Marozzi, A. (2006) · Human Reproduction · doi:10.1093/humrep/dei432 · Cited by 170
Prevalence of the fragile X syndrome in African‐Americans
Crawford, D. C., Meadows, K. L., Newman, J. L., Taft, L. F., Scott, E., Leslie, M., Shubeck, L., Holmgreen, P., Yeargin‐Allsopp, M., Boyle, C. A., et al. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10427 · Cited by 150
Fragile X AGG analysis provides new risk predictions for 45–69 repeat alleles
Nolin, S. L., Sah, S., Glicksman, A., Sherman, S. L., Allen, E. G., Berry‐Kravis, E., Tassone, F., Yrigollen, C. M., Cronister, A., Jodah, M., et al. (2013) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.35833 · Cited by 129
Self-citationPreconceptional and prenatal screening for fragile X syndrome: Experience with 40 000 tests
Berkenstadt, M., Ries‐Levavi, L., Cuckle, H., Peleg, L., & Barkai, G. (2007) · Prenatal Diagnosis · doi:10.1002/pd.1815 · Cited by 124
FRAXA and FRAXE: the results of a five year survey
Youings, S. A., Murray, A., Dennis, N., Ennis, S., Lewis, C., McKechnie, N., Pound, M., Sharrock, A., & Jacobs, P. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.6.415 · Cited by 120
Loesch, D. Z., Bui, M., Huggins, R., Mitchell, R. J., Hagerman, R. J., & Tassone, F. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2006.043950 · Cited by 117
Self-citationFragile X Syndrome and Targeted Treatment Trials
Hagerman, R. J., Lauterborn, J. C., Au, J., & Berry‐Kravis, E. (2011) · Results and problems in cell differentiation · doi:10.1007/978-3-642-21649-7_17 · Cited by 117
Self-citationSize bias of fragile X premutation alleles in late-onset movement disorders
Jacquemont, S., Leehey, M. A., Hagerman, R. J., Beckett, L. A., & Hagerman, P. J. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2006.042374 · Cited by 116
Self-citationScreening for fragile X syndrome: a literature review and modelling study
Song, F., Barton, P., Sleightholme, V., Yao, G., & Fry-Smith, A. (2003) · Health Technology Assessment · doi:10.3310/hta7160 · Cited by 114
Feasibility and acceptance of screening for fragile X mutations in low-risk pregnancies
Ryynänen, M., Heinonen, S. T., Makkonen, M., Kajanoja, E., Mannermaa, A., & Pertti, K. (1999) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200285 · Cited by 112
Godler, D. E., Tassone, F., Loesch, D. Z., Taylor, A. K., Gehling, F., Hagerman, R. J., Burgess, T., Ganesamoorthy, D., Hennerich, D., Gordon, L., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq037 · Cited by 110
Self-citationChonchaiya, W., Au, J., Schneider, A., Hessl, D., Harris, S. W., Laird, M., Mu, Y., Tassone, F., Nguyen, D. V., & Hagerman, R. J. (2012) · Human Genetics · doi:10.1007/s00439-011-1106-6 · Cited by 109
Self-citationHantash, F. M., Goos, D. M., Crossley, B., Anderson, B., Zhang, K., Sun, W., & Strom, C. M. (2010) · Genetics in Medicine · doi:10.1097/gim.0b013e3181fa9fad · Cited by 105
McDuffie, A. S., Abbeduto, L., Lewis, P. F., Kover, S. T., Kim, J.-S., Weber, A., & Brown, W. T. (2010) · American Journal on Intellectual and Developmental Disabilities · doi:10.1352/1944-7558-115.4.307 · Cited by 101
Small CGG repeat expansion alleles of FMR1 gene are associated with parkinsonism
Loesch, D. Z., Khaniani, M. S., Slater, H., Rubio, J. P., Bui, M., Kotschet, K. E., D'Souza, W. J., Venn, A., Kalitsis, P., Choo, A., et al. (2009) · Clinical Genetics · doi:10.1111/j.1399-0004.2009.01275.x · Cited by 100
Lyon, E., Laver, T. A., Yu, P., Jama, M., Young, K., Zoccoli, M. A., & Marlowe, N. (2010) · Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2010.090229 · Cited by 97
Fragile X carrier screening and FMR1 allele distribution in the Japanese population
Otsuka, S., Sakamoto, Y., Siomi, H., Itakura, M., Yamamoto, K., Matumoto, H., Sasaki, T., Kato, N., & Nanba, E. (2009) · Brain and Development · doi:10.1016/j.braindev.2008.12.015 · Cited by 96
Watson, M. S., Lloyd-Puryear, M. A., Mann, M. Y., Rinaldo, P., & Howell, R. R. (2006) · Genetics in Medicine · doi:10.1097/01.gim.0000223467.60151.02 · Cited by 93
Fragile X syndrome is less common than previously estimated
Morton, J. E., Bundey, S., Webb, T. P., MacDonald, F., Rindl, P. M., & Bullock, S. (1997) · Journal of Medical Genetics · doi:10.1136/jmg.34.1.1 · Cited by 92
Hantash, F. M., Goos, D. M., Tsao, D., Quan, F., Buller‐Burckle, A., Peng, M., Jarvis, M., Sun, W., & Strom, C. M. (2010) · Genetics in Medicine · doi:10.1097/gim.0b013e3181d0d40e · Cited by 83
Fragile X–associated tremor ataxia syndrome in FMR1 gray zone allele carriers
Hall, D. A., Tassone, F., Klepitskaya, O., & Leehey, M. A. (2011) · Movement Disorders · doi:10.1002/mds.24021 · Cited by 76
Self-citationSelection of Diseases and Tests in Pediatric Screening
Frankenburg, W. K. (1974) · PEDIATRICS · doi:10.1542/peds.54.5.612 · Cited by 75
Sleep apnea in fragile X premutation carriers with and without FXTAS
Hamlin, A. A., Liu, Y., Nguyen, D. V., Tassone, F., Zhang, L., & Hagerman, R. J. (2011) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31237 · Cited by 64
Self-citationWinarni, T. I., Schneider, A., Borodyanskara, M., & Hagerman, R. J. (2012) · Case Reports in Genetics · doi:10.1155/2012/280813 · Cited by 59
Self-citationHamlin, A. A., Sukharev, D., Campos, L., Mu, Y., Tassone, F., Hessl, D. R., Nguyen, D. V., Loesch, D. Z., & Hagerman, R. J. (2012) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.35323 · Cited by 59
Self-citationTzeng, C., Tsai, L., Hwu, W., Lin, S., Chao, M., Jong, Y., Chu, S., Chao, W.-C., & Lu, C. (2005) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.30528 · Cited by 58
Evidence of depressive symptoms in fragile-X syndrome premutated females
Rodríguez‐Revenga, L., Madrigal, I., Alegret, M., Santos, M., & Milà, M. (2008) · Psychiatric Genetics · doi:10.1097/ypg.0b013e3282f97e0b · Cited by 58
Fragile X‐associated tremor/ataxia syndrome ( FXTAS ) in grey zone carriers
Liu, Y., Winarni, T. I., Zhang, L., Tassone, F., & Hagerman, R. J. (2012) · Clinical Genetics · doi:10.1111/cge.12026 · Cited by 57
Self-citationIncidence of Fragile X in 5,000 Consecutive Newborn Males
Rife, M. F., Bádenas, C., Mallolas, J., Jiménez, L., Cervera, R., Maya, A. C. L., Glover, G., Rivera, F., & Milà, M. (2003) · Genetic Testing · doi:10.1089/109065703322783725 · Cited by 56
Metcalfe, S. A., Jacques, A., Archibald, A. D., Burgess, T., Collins, V., Henry, A., McNamee, K. M., Sheffield, L. J., Slater, H. R., Wake, S., et al. (2008) · Genetics in Medicine · doi:10.1097/gim.0b013e31817c036e · Cited by 56
Fibromyalgia in fragile X mental retardation 1 gene premutation carriers
Leehey, M. A., Legg, W. E., Tassone, F., & Hagerman, R. J. (2011) · Rheumatology · doi:10.1093/rheumatology/ker273 · Cited by 56
Self-citationFragile X syndrome carrier screening in the prenatal genetic counseling setting
Cronister, A., DiMaio, M. S., Mahoney, M. J., Donnenfeld, A. E., & Hallam, S. (2005) · Genetics in Medicine · doi:10.1097/01.gim.0000159898.90221.d3 · Cited by 54
Visual attention and autistic behavior in infants with fragile X syndrome
Roberts, J. E., Hatton, D. D., Long, A. C. J., Anello, V., & Colombo, J. (2012) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-011-1316-8 · Cited by 50
FMR1 gray‐zone alleles: Association with Parkinson's disease in women?
Hall, D. A., Berry‐Kravis, E., Zhang, W., Tassone, F., Spector, E., Zerbe, G. O., Hagerman, P. J., Ouyang, B., & Leehey, M. A. (2011) · Movement Disorders · doi:10.1002/mds.23755 · Cited by 49
Self-citationDawson, A., Chodirker, B. N., & Chudley, A. E. (1995) · Biochemical and Molecular Medicine · doi:10.1006/bmme.1995.1057 · Cited by 49
Spencer, K., Ong, C. Y. T., Liao, A. W., Papademetriou, D., & Nicolaides, K. H. (2000) · Prenatal Diagnosis · doi:10.1002/1097-0223(200008)20:8<611::aid-pd881>3.0.co;2-m · Cited by 48
Parents' Decisions to Screen Newborns forFMR1Gene Expansions in a Pilot Research Project
Skinner, D., Choudhury, S., Sideris, J. H., Guarda, S., Buansi, A., Roche, M. I., Powell, C. M., & Bailey, D. B. (2011) · PEDIATRICS · doi:10.1542/peds.2010-3078 · Cited by 48
Self-citationMolecular fragile X screening in normal populations
Spence, W. C., Black, S. H., Fallon, L. A., Maddalena, A., Cummings, E. L., Menapace-Drew, G. F., Bick, D. P., Levinson, G., Schulman, J. D., & Howard‐Peebles, P. N. (1996) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19960712)64:1<181::aid-ajmg31>3.0.co;2-h · Cited by 46
Lévesque, S., Dombrowski, C., Morel, M., Réhel, R., Côté, J., Bussières, J., Morgan, K., & Rousseau, F. (2009) · Clinical Genetics · doi:10.1111/j.1399-0004.2009.01237.x · Cited by 46
Cosmetic Therapies in Obstetrics and Gynecology Practice: Putting a Toe in the Water?
Laube, D. W. (2008) · Obstetrics and Gynecology · doi:10.1097/gim.0b013e3181862a76 · Cited by 35
Broad Clinical Involvement in a Family Affected by the Fragile X Premutation
Chonchaiya, W., Utari, A., Pereira, G. M., Tassone, F., Hessl, D. R., & Hagerman, R. J. (2009) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0b013e3181c35f25 · Cited by 35
Self-citationStrom, C. M., Huang, D., Li, Y., Hantash, F. M., Rooke, J. E., Potts, S. J., & Sun, W. (2007) · Genetics in Medicine · doi:10.1097/gim.0b013e31803d3ac9 · Cited by 31
Newborn screening and cascade testing for FMR1 mutations
Sorensen, P. L., Gane, L. W., Yarborough, M. A., Hagerman, R. J., & Tassone, F. (2012) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.35680 · Cited by 30
Self-citationChonchaiya, W., Tassone, F., Ashwood, P., Hessl, D. R., Schneider, A., Campos, L., Nguyen, D. V., & Hagerman, R. J. (2010) · Human Genetics · doi:10.1007/s00439-010-0882-8 · Cited by 30
Self-citationGeva, E., Yaron, Y., Shomrat, R., Ben‐Yehuda, A., Zabari, S., Peretz, H., Naiman, T., Yeger, H., & Orr‐Urtreger, A. (2000) · Genetic Testing · doi:10.1089/10906570050501524 · Cited by 29
The Fragile X-Associated Tremor Ataxia Syndrome (FXTAS)
Tassone, F., & Berry‐Kravis, E. (2010) · Springer eBooks · doi:10.1007/978-1-4419-5805-1 · Cited by 24
Self-citationSherman, S. L., Marsteller, F., Abramowitz, A. J., Scott, E., Leslie, M., & Bregman, J. D. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10303 · Cited by 21
Commentary on population screening for fragile X syndrome
Coffee, B. W. (2010) · Genetics in Medicine · doi:10.1097/gim.0b013e3181e5c804 · Cited by 17
Drasinover, V., Ehrlich, S., Magal, N., Taub, E., Libman, V., Shohat, T., Halpern, G. J., & Shohat, M. (2000) · American Journal of Medical Genetics · Cited by 14
Turner (1996) · doi:10.1002/(sici)1096-8628(19960712)64:1<196::aid-ajmg35>3.0.co;2-g
Cited by
Hagerman, R. J., Berry-Kravis, E., Hazlett, H. C., Bailey, D. B., Moine, H., Kooy, R. F., Tassone, F., Gantois, I., Sonenberg, N., Mandel, J. L., et al. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.65 · Cited by 838
Self-citationHagerman, R., & Hagerman, P. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70125-x · Cited by 313
Self-citationFragile X-associated tremor/ataxia syndrome — features, mechanisms and management
Hagerman, R. J., & Hagerman, P. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.82 · Cited by 290
Self-citationAutism spectrum disorder in fragile X syndrome: cooccurring conditions and current treatment
Kaufmann, W. E., Kidd, S. A., Andrews, H. F., Budimirovic, D. B., Esler, A., Haas-Givler, B., Stackhouse, T., Riley, C., Peacock, G., Sherman, S. L., et al. (2017) · PEDIATRICS · doi:10.1542/peds.2016-1159f · Cited by 268
“KAUFMANN et al S196 frequent sleep problems requiring treatment in the FXS+ASD group, especially in children (based on data in idiopathic ASD); (3) behavioral problems would be increased in the group with FXS+ASD in both age groups, particularly irritability/ aggression, perseverative/obsessive compulsive behavior, an…”
BackgroundFragile X-Associated Neuropsychiatric Disorders (FXAND)
Hagerman, R. J., Protic, D., Rajaratnam, A., Salcedo-Arellano, M. J., Aydin, E. Y., & Schneider, A. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00564 · Cited by 204
Self-citation
Metadata
- Authors
- Tassone, F., Iong, K. P., Tong, T.-H., Lo, J., Gane, L. W., Berry-Kravis, E., Nguyen, D., Mu, L. Y., Laffin, J., Bailey, D. B., & Hagerman, R. J.
- Venue
- Genome Medicine
- Published
- 2012-12-21
- Volume
- 4
- Issue
- 12
- Pages
- 100-100
- ISSN
- 1756-994X (ISSN-L)
- OpenAlex
- W2088094988
- Cited by
- 315
- References
- 85
- FWCI
- 11.69
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.